News

0

Press Release: Noventure acquires Ulkox® and Oleoabrax®, two medical devices based on patented new wound-healing technology

• Acquisition allows Noventure to maintain focus on medical devices and grow therapeutic areas in which it operates • Medical devices contain Olea Europaea leaf extract, showing healing properties for ulcers and skin wounds • Innovative products are CE marked and available for licensing worldwide Barcelona, Spain, April 19, 2021 – Noventure, specialized in licensing innovative substance-based medical devices and specialist food supplements, today announces it has acquired the Ulkox® and Oleoabrax® products, based on an Olea Europaea leaf extract wound-healing technology.

Read more

Press Release: Noventure signs exclusive license agreement for innovative food supplement EPA3G

• EPA3G a unique, patented emulsion of high purity EPA, in drinkable single sachet - containing daily dose of 3g • Deal gives Noventure licensing rights in over 50 countries • Agreement signed with global partner Azur Global Nutrition Barcelona, Spain, February 17th, 2021 - Noventure announces today that it has signed an exclusivity agreement for the licensing of the innovative food supplement EPA3G, with global partner Azur – a division of Solutex (Madrid, Spain).

Read more

Let's meet in..

2021, May 27

PharmaVenue Berlin

Read more

2021, Jun 02

ESPGHAN 6th World Congress

Read more

2021, Jun 14

euroPLX 76 Noordijk

Read more